Enhanced Tim3 activity improves survival after influenza infection

Journal of Immunology

Volumn 189, Issue 6, 2012, Pages 2879-2889

  Cho, Josalyn L ^a   Roche, Marly I ^a   Sandall, Barry ^a   Brass, Abraham L ^a,b   Seed, Brian ^a   Xavier, Ramnik J ^a   Medoff, Benjamin D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; MUCIN; MUCIN DOMAIN 3; T LYMPHOCYTE RECEPTOR DELTA CHAIN; UNCLASSIFIED DRUG;

2009 H1N1 INFLUENZA; ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; GENE; GENE ACTIVATION; GENE ACTIVITY; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; IMMUNOREGULATION; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SURVIVAL; TIM3 GENE; VIRAL CLEARANCE; VIRUS PNEUMONIA;

ANIMALS; ANTIGENS, CD3; CD8-POSITIVE T-LYMPHOCYTES; CYTOTOXICITY, IMMUNOLOGIC; DISEASE MODELS, ANIMAL; DOWN-REGULATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; ORTHOMYXOVIRIDAE INFECTIONS; PHOSPHORYLATION; RECEPTORS, VIRUS; SEQUENCE DELETION; SIGNAL TRANSDUCTION; SURVIVAL ANALYSIS; UP-REGULATION;

EID: 84866149955     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102483     Document Type: Article

References (71)

1. Murphy, B. R., and R. G. Webster. 1996. Orthomyxoviruses. In Fields Virology. B. N. Fields, D. M. Knipe, P. M. Howley, et al., eds. Lippincott-Raven Publishers, Philadelphia. p. 1397-1445.
2. Couch, R. B. 2000. Influenza: prospects for control. Ann. Intern. Med. 133: 992-998. (Pubitemid 32003515)
3. Simonsen, L., K. Fukuda, L. B. Schonberger, and N. J. Cox. 2000. The impact of influenza epidemics on hospitalizations. J. Infect. Dis. 181: 831-837. (Pubitemid 30194462)
4. Heltzer, M. L., S. E. Coffin, K. Maurer, A. Bagashev, Z. Zhang, J. S. Orange, and K. E. Sullivan. 2009. Immune dysregulation in severe influenza. J. Leukoc. Biol. 85: 1036-1043.
5. de Jong, M. D., C. P. Simmons, T. T. Thanh, V. M. Hien, G. J. Smith, T. N. Chau, D. M. Hoang, N. V. Chau, T. H. Khanh, V. C. Dong, et al. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12: 1203-1207.
6. Kash, J. C., T. M. Tumpey, S. C. Proll, V. Carter, O. Perwitasari, M. J. Thomas, C. F. Basler, P. Palese, J. K. Taubenberger, A. García-Sastre, et al. 2006. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443: 578-581. (Pubitemid 44527293)
7. Sullivan, K. M., A. S. Monto, and I. M. Longini, Jr. 1993. Estimates of the US health impact of influenza. Am. J. Public Health 83: 1712-1716. (Pubitemid 24009500)
8. Bermejo-Martin, J. F., I. Martin-Loeches, J. Rello, A. Antón, R. Almansa, L. Xu, G. Lopez-Campos, T. Pumarola, L. Ran, P. Ramirez, et al. 2010. Host adaptive immunity deficiency in severe pandemic influenza. Crit. Care 14: R167.
9. Hagau, N., A. Slavcovici, D. N. Gonganau, S. Oltean, D. S. Dirzu, E. S. Brezoszki, M. Maxim, C. Ciuce, M. Mlesnite, R. L. Gavrus, et al. 2010. Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit. Care 14: R203.
10. Mauad, T., L. A. Hajjar, G. D. Callegari, L. F. da Silva, D. Schout, F. R. Galas, V. A. Alves, D. M. Malheiros, J. O. Auler, Jr., A. F. Ferreira, et al. 2010. Lung pathology in fatal novel human influenza A (H1N1) infection. Am. J. Respir. Crit. Care Med. 181: 72-79.
11. Nin, N., L. Soto, J. Hurtado, J. A. Lorente, M. Buroni, F. Arancibia, S. Ugarte, H. Bagnulo, P. Cardinal, G. Bugedo, et al. 2011. Clinical characteristics and outcomes of patients with 2009 influenza A(H1N1) virus infection with respiratory failure requiring mechanical ventilation. J. Crit. Care 26: 186-192.
12. Salomon, R., E. Hoffmann, and R. G. Webster. 2007. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl. Acad. Sci. USA 104: 12479-12481. (Pubitemid 47206163)
13. Salomon, R., and R. G. Webster. 2009. The influenza virus enigma. Cell 136: 402-410.
14. Szretter, K. J., S. Gangappa, X. Lu, C. Smith, W. J. Shieh, S. R. Zaki, S. Sambhara, T. M. Tumpey, and J. M. Katz. 2007. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J. Virol. 81: 2736-2744. (Pubitemid 46447038)
15. Cameron, C. M., M. J. Cameron, J. F. Bermejo-Martin, L. Ran, L. Xu, P. V. Turner, R. Ran, A. Danesh, Y. Fang, P. K. Chan, et al. 2008. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J. Virol. 82: 11308-11317.
16. Kuchroo, V. K., V. Dardalhon, S. Xiao, and A. C. Anderson. 2008. New roles for TIM family members in immune regulation. Nat. Rev. Immunol. 8: 577-580.
17. Monney, L., C. A. Sabatos, J. L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E. A. Greenfield, A. J. Coyle, R. A. Sobel, et al. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541. (Pubitemid 34130609)
18. Oikawa, T., Y. Kamimura, H. Akiba, H. Yagita, K. Okumura, H. Takahashi, M. Zeniya, H. Tajiri, and M. Azuma. 2006. Preferential involvement of Tim-3 in the regulation of hepatic CD8+ T cells in murine acute graft-versus-host disease. J. Immunol. 177: 4281-4287. (Pubitemid 44469756)
19. Sánchez-Fueyo, A., J. Tian, D. Picarella, C. Domenig, X. X. Zheng, C. A. Sabatos, N. Manlongat, O. Bender, T. Kamradt, V. K. Kuchroo, et al. 2003. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 4: 1093-1101. (Pubitemid 37428037)
20. Jones, R. B., L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205: 2763-2779.
21. Sehrawat, S., P. B. Reddy, N. Rajasagi, A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2010. Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog. 6: e1000882.
22. Sehrawat, S., A. Suryawanshi, M. Hirashima, and B. T. Rouse. 2009. Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J. Immunol. 182: 3191-3201.
23. Zhu, C., A. C. Anderson, A. Schubart, H. Xiong, J. Imitola, S. J. Khoury, X. X. Zheng, T. B. Strom, and V. K. Kuchroo. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6: 1245-1252. (Pubitemid 43045636)
24. Hastings, W. D., D. E. Anderson, N. Kassam, K. Koguchi, E. A. Greenfield, S. C. Kent, X. X. Zheng, T. B. Strom, D. A. Hafler, and V. K. Kuchroo. 2009. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur. J. Immunol. 39: 2492-2501.
25. Anderson, A. C., D. E. Anderson, L. Bregoli, W. D. Hastings, N. Kassam, C. Lei, R. Chandwaskar, J. Karman, E. W. Su, M. Hirashima, et al. 2007. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318: 1141-1143. (Pubitemid 350134897)
26. Hirashima, M., Y. Kashio, N. Nishi, A. Yamauchi, T. A. Imaizumi, T. Kageshita, N. Saita, and T. Nakamura. 2004. Galectin-9 in physiological and pathological conditions. Glycoconj. J. 19: 593-600. (Pubitemid 38460942)
27. Dai, S. Y., R. Nakagawa, A. Itoh, H. Murakami, Y. Kashio, H. Abe, S. Katoh, K. Kontani, M. Kihara, S. L. Zhang, et al. 2005. Galectin-9 induces maturation of human monocyte-derived dendritic cells. J. Immunol. 175: 2974-2981. (Pubitemid 41170515)
28. Imaizumi, T., M. Kumagai, N. Sasaki, H. Kurotaki, F. Mori, M. Seki, N. Nishi, K. Fujimoto, K. Tanji, T. Shibata, et al. 2002. Interferon-gamma stimulates the expression of galectin-9 in cultured human endothelial cells. J. Leukoc. Biol. 72: 486-491.
29. van de Weyer, P. S., M. Muehlfeit, C. Klose, J. V. Bonventre, G. Walz, and E. W. Kuehn. 2006. A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem. Biophys. Res. Commun. 351: 571-576. (Pubitemid 44666725)
30. Lee, J., E. W. Su, C. Zhu, S. Hainline, J. Phuah, J. A. Moroco, T. E. Smithgall, V. K. Kuchroo, and L. P. Kane. 2011. Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol. Cell. Biol. 31: 3963-3974.
31. Sabatos, C. A., S. Chakravarti, E. Cha, A. Schubart, A. Sánchez-Fueyo, X. X. Zheng, A. J. Coyle, T. B. Strom, G. J. Freeman, and V. K. Kuchroo. 2003. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 4: 1102-1110. (Pubitemid 37428038)
32. Seki, M., S. Oomizu, K. M. Sakata, A. Sakata, T. Arikawa, K. Watanabe, K. Ito, K. Takeshita, T. Niki, N. Saita, et al. 2008. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 127: 78-88.
33. Wang, F., W. He, J. Yuan, K. Wu, H. Zhou, W. Zhang, and Z. K. Chen. 2008. Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts. Transpl. Immunol. 19: 12-19.
34. Wang, F., W. He, H. Zhou, J. Yuan, K. Wu, L. Xu, and Z. K. Chen. 2007. The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft. Cell. Immunol. 250: 68-74.
35. Medoff, B. D., B. Seed, R. Jackobek, J. Zora, Y. Yang, A. D. Luster, and R. Xavier. 2006. CARMA1 is critical for the development of allergic airway inflammation in a murine model of asthma. J. Immunol. 176: 7272-7277. (Pubitemid 43849027)
36. Medoff, B. D., E. Seung, J. C. Wain, T. K. Means, G. S. Campanella, S. A. Islam, S. Y. Thomas, L. C. Ginns, N. Grabie, A. H. Lichtman, et al. 2005. BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J. Exp. Med. 202: 97-110. (Pubitemid 41002913)
37. Mikhak, Z., M. Fukui, A. Farsidjani, B. D. Medoff, A. M. Tager, and A. D. Luster. 2009. Contribution of CCR4 and CCR8 to antigen-specific T(H)2 cell trafficking in allergic pulmonary inflammation. J. Allergy Clin. Immunol. 123: 67-73.e3.
38. Topham, D. J., M. R. Castrucci, F. S. Wingo, G. T. Belz, and P. C. Doherty. 2001. The role of antigen in the localization of naive, acutely activated, and memory CD8(+) T cells to the lung during influenza pneumonia. J. Immunol. 167: 6983-6990. (Pubitemid 33144193)
39. Brass, A. L., I. C. Huang, Y. Benita, S. P. John, M. N. Krishnan, E. M. Feeley, B. J. Ryan, J. L. Weyer, L. van der Weyden, E. Fikrig, et al. 2009. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139: 1243-1254.
40. Huang, I. C., W. Li, J. Sui, W. Marasco, H. Choe, and M. Farzan. 2008. Influenza A virus neuraminidase limits viral superinfection. J. Virol. 82: 4834-4843. (Pubitemid 351657045)
41. Seder, R. A., and R. Ahmed. 2003. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat. Immunol. 4: 835-842. (Pubitemid 37098653)
42. Smith-Garvin, J. E., G. A. Koretzky, and M. S. Jordan. 2009. T cell activation. Annu. Rev. Immunol. 27: 591-619.
43. Lawrence, C. W., and T. J. Braciale. 2004. Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J. Immunol. 173: 1209-1218. (Pubitemid 38924298)
44. Román, E., E. Miller, A. Harmsen, J. Wiley, U. H. Von Andrian, G. Huston, and S. L. Swain. 2002. CD4 effector T cell subsets in the response to influenza: heterogeneity, migration, and function. J. Exp. Med. 196: 957-968.
45. Kohlmeier, J. E., and D. L. Woodland. 2009. Immunity to respiratory viruses. Annu. Rev. Immunol. 27: 61-82.
46. Eichelberger, M., W. Allan, M. Zijlstra, R. Jaenisch, and P. C. Doherty. 1991. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp. Med. 174: 875-880.
47. Flynn, K. J., G. T. Belz, J. D. Altman, R. Ahmed, D. L. Woodland, and P. C. Doherty. 1998. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity 8: 683-691. (Pubitemid 28294515)
48. Xu, L., H. Yoon, M. Q. Zhao, J. Liu, C. V. Ramana, and R. I. Enelow. 2004. Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J. Immunol. 173: 721-725. (Pubitemid 38924244)
49. Moskophidis, D., and D. Kioussis. 1998. Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J. Exp. Med. 188: 223-232. (Pubitemid 28357751)
50. Seung, E., J. L. Cho, T. Sparwasser, B. D. Medoff, and A. D. Luster. 2011. Inhibiting CXCR3-dependent CD8+ T cell trafficking enhances tolerance induction in a mouse model of lung rejection. J. Immunol. 186: 6830-6838.
51. Sharma, S., A. Sundararajan, A. Suryawanshi, N. Kumar, T. Veiga-Parga, V. K. Kuchroo, P. G. Thomas, M. Y. Sangster, and B. T. Rouse. 2011. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc. Natl. Acad. Sci. USA 108: 19001-19006.
52. Kuchroo, V. K., J. H. Meyers, D. T. Umetsu, and R. H. DeKruyff. 2006. TIM family of genes in immunity and tolerance. Adv. Immunol. 91: 227-249. (Pubitemid 44286997)
53. Su, E. W., J. Y. Lin, and L. P. Kane. 2008. TIM-1 and TIM-3 proteins in immune regulation. Cytokine 44: 9-13.
54. Kane, L. P. 2010. T cell Ig and mucin domain proteins and immunity. J. Immunol. 184: 2743-2749.
55. Obenauer, J. C. C. L., and M. B. Yaffe. Available at: http://scansite.mit.edu/index.html. Accessed: October 4, 2010.
56. Chandok, M. R., and D. L. Farber. 2004. Signaling control of memory T cell generation and function. Semin. Immunol. 16: 285-293. (Pubitemid 39446556)
57. Kimachi, K., K. Sugie, and H. M. Grey. 2003. Effector T cells have a lower ligand affinity threshold for activation than naive T cells. Int. Immunol. 15: 885-892. (Pubitemid 36827077)
58. Teixeiro, E., M. A. Daniels, S. E. Hamilton, A. G. Schrum, R. Bragado, S. C. Jameson, and E. Palmer. 2009. Different T cell receptor signals determine CD8+ memory versus effector development. Science 323: 502-505.
59. Binné, L. L., M. L. Scott, and P. D. Rennert. 2007. Human TIM-1 associates with the TCR complex and up-regulates T cell activation signals. J. Immunol. 178: 4342-4350. (Pubitemid 46492385)
60. Baniyash, M. 2004. TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response. Nat. Rev. Immunol. 4: 675-687. (Pubitemid 39223074)
61. Fourcade, J., Z. Sun, M. Benallaoua, P. Guillaume, I. F. Luescher, C. Sander, J. M. Kirkwood, V. Kuchroo, and H. M. Zarour. 2010. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J. Exp. Med. 207: 2175-2186.
62. Golden-Mason, L., B. E. Palmer, N. Kassam, L. Townshend-Bulson, S. Livingston, B. J. McMahon, N. Castelblanco, V. Kuchroo, D. R. Gretch, and H. R. Rosen. 2009. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J. Virol. 83: 9122-9130.
63. McMahan, R. H., L. Golden-Mason, M. I. Nishimura, B. J. McMahon, M. Kemper, T. M. Allen, D. R. Gretch, and H. R. Rosen. 2010. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J. Clin. Invest. 120: 4546-4557.
64. Bender, B. S., and P. A. Small, Jr. 1992. Influenza: pathogenesis and host defense. Semin. Respir. Infect. 7: 38-45.
65. Harmsen, A. G., B. A. Muggenburg, M. B. Snipes, and D. E. Bice. 1985. The role of macrophages in particle translocation from lungs to lymph nodes. Science 230: 1277-1280. (Pubitemid 16194534)
66. Cerwenka, A., T. M. Morgan, and R. W. Dutton. 1999. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial. J. Immunol. 163: 5535-5543.
67. Epstein, S. L., C. Y. Lo, J. A. Misplon, and J. R. Bennink. 1998. Mechanism of protective immunity against influenza virus infection in mice without antibodies. J. Immunol. 160: 322-327. (Pubitemid 28116745)
68. Graham, M. B., and T. J. Braciale. 1997. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J. Exp. Med. 186: 2063-2068. (Pubitemid 28013692)
69. Allan, W., Z. Tabi, A. Cleary, and P. C. Doherty. 1990. Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. J. Immunol. 144: 3980-3986. (Pubitemid 20171213)
70. Topham, D. J., R. A. Tripp, and P. C. Doherty. 1997. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 159: 5197-5200. (Pubitemid 127470043)
71. Doherty, P. C., D. J. Topham, R. A. Tripp, R. D. Cardin, J. W. Brooks, and P. G. Stevenson. 1997. Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunol. Rev. 159: 105-117. (Pubitemid 27499863)